United States v. Arthrex Inc.: Post-Argument Debrief on the Constitutionality of IPRs

The Supreme Court recently heard the argument in United States v. Arthrex Inc., about the constitutionality of inter partes review (IPR), the morning of March 1, 2021. Following the argument, experts from both Goodwin’s Supreme Court and Appellate practice and its Patent Trial and Appeal Board (PTAB) practice discussed their forecast about whether IPR will survive in its current form and what the next steps would be depending on the outcome.

View the Video

*Please note that our webinar and event recordings are for informational purposes only; CLE credit is only available for our guests attending live webinars and other events.